Life sciences briefing: Tuesday, Aug. 21, 2007
(UPDATED at 7:40pm PT: See below.)
Featured companies: Adnexus Therapeutics, BioForm Medical, Confirma, Cardiovascular Systems, Mirabilis Medica, Neuromed Pharmaceuticals, PlaCor, Seno Medical Instruments, Vibrynt
BioForm Medical files $115M IPO for “medical aesthetics” — BioForm Medical, a San Mateo, Calif., developer of wrinkle fillers and other products for cosmetic procedures, filed to raise $115 million in an initial offering. BioForm’s major customers are plastic surgeons and dermatologists.
BioForm, however, takes pains to describe itself differently on its Web site…. Continue Reading
Halt Medical raises $12M for fibroids device
Halt Medical, a secretive Pleasanton, Calif., company, has raised $12 million in a third funding round as it prepares for human trials of a device designed to remove uterine fibroids without hysterectomy, VentureWire is reporting (subscription required).
Uterine fibroids — also sometimes known as fibromyomas, leiomyomas or myomas — are noncancerous growths of the uterus. Although generally not threatening to health, these fibroids can sometimes cause complications ranging from pain and heavy menstrual bleeding to backache,… Continue Reading